PHR Phreesia, Inc.
NYSE · SEC CIK 1412408 · EDGAR
- Bought, last 12 months
- $28.77M 2 purchases by 2 insiders
- Sold, last 12 months
- $2.18M 37 sales by 8 insiders
- Filings on record
- 566 since 2021-07-12, latest 2026-09-22 16:34
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Pale Fire Capital SICAV a.s. | 10% | $18.30M | — |
| Pale Fire Capital SE | 10% | $10.46M | — |
| Hoffman Allison C | GC, Sec | — | $537.1K |
| Indig Chaim | CEO, Dir | — | $421.0K |
| Linetsky David | Pres, Network Solutions | — | $347.2K |
| Gandhi Balaji | CFO | — | $291.8K |
| Roberts Evan | Pres, Provider Solutions | — | $281.9K |
| Hui Yvonne | Principal Accounting Off | — | $168.5K |
| VanDuyn Amy Beth | SVP, Human Resources | — | $105.8K |
| Egbuonu-Davis Lisa | Dir | — | $30.0K |
Transactions 672
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-01 | 2024-07-31 | PHR | Goldstein Lainie | Dir | A - Grant | $24.95 | +400 | 40.6K | +1.0% | +$9,980 | |
| 2024-08-01 | 2024-07-31 | PHR | Munson Gillian | Dir | A - Grant | $24.95 | +400 | 36.2K | +1% | +$9,980 | |
| 2024-08-01 | 2024-07-31 | PHR | CAHILL EDWARD L | Dir | A - Grant | $24.95 | +400 | 46.5K | +0.9% | +$9,980 | |
| D | 2024-07-30 | 2024-07-29 | PHR | Indig Chaim | CEO, Dir | M - OptEx | $2.03 | +7 | 1.22M | +0.0% | +$14.21 |
| D | 2024-07-30 | 2024-07-29 | PHR | Indig Chaim | CEO, Dir | S - Sale+OE | $24.75 | -7 | 1.22M | -0.0% | -$173.25 |
| D | 2024-07-22 | 2024-07-18 | PHR | Smith Mark Douglas | Dir | M - OptEx | $4.71 | +7,000 | 37.7K | +23% | +$33.0K |
| D | 2024-07-22 | 2024-07-18 | PHR | Smith Mark Douglas | Dir | S - Sale+OE | $25.00 | -7,000 | 30.7K | -19% | -$175.0K |
| 2024-07-17 | 2024-07-16 | PHR | VanDuyn Amy Beth | SVP, Human Resources | S - Sale | $23.74 | -374 | 118.6K | -0.3% | -$8,879 | |
| 2024-07-17 | 2024-07-16 | PHR | Indig Chaim | CEO, Dir | S - Sale | $23.74 | -2,644 | 1.22M | -0.2% | -$62.8K | |
| 2024-07-17 | 2024-07-16 | PHR | Roberts Evan | COO | S - Sale | $23.74 | -1,669 | 753.2K | -0.2% | -$39.6K | |
| 2024-07-17 | 2024-07-16 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $23.74 | -1,820 | 202.2K | -0.9% | -$43.2K | |
| 2024-07-17 | 2024-07-16 | PHR | Gandhi Balaji | CFO | S - Sale | $23.74 | -783 | 96.4K | -0.8% | -$18.6K | |
| 2024-07-17 | 2024-07-15 | PHR | Hui Yvonne | Principal Accounting Off | A - Grant | $22.82 | +13.0K | 29.0K | +81% | +$296.7K | |
| 2024-07-17 | 2024-07-16 | PHR | Hui Yvonne | Principal Accounting Off | S - Sale | $23.74 | -283 | 28.7K | -1.0% | -$6,718 | |
| 2024-07-17 | 2024-07-16 | PHR | Hoffman Allison C | GC, Sec | S - Sale | $23.74 | -800 | 135.1K | -0.6% | -$19.0K | |
| 2024-07-02 | 2024-06-28 | PHR | Hoffman Allison C | GC, Sec | A - Grant | $18.02 | +292 | 135.9K | +0.2% | +$5,262 | |
| 2024-07-02 | 2024-06-28 | PHR | Hui Yvonne | Principal Accounting Off | A - Grant | $18.02 | +740 | 16.0K | +5% | +$13.3K | |
| 2024-06-28 | 2024-06-26 | PHR | Smith Mark Douglas | Dir | A - Grant | $0.00 | +8,490 | 30.7K | +38% | $0 | |
| 2024-06-28 | 2024-06-26 | PHR | CAHILL EDWARD L | Dir | A - Grant | $0.00 | +8,490 | 54.6K | +18% | $0 | |
| 2024-06-28 | 2024-06-26 | PHR | Sayar Ramin | Dir | A - Grant | $0.00 | +8,490 | 26.7K | +47% | $0 | |
| 2024-06-28 | 2024-06-26 | PHR | Munson Gillian | Dir | A - Grant | $0.00 | +8,490 | 35.8K | +31% | $0 | |
| 2024-06-28 | 2024-06-26 | PHR | Weintraub Michael | Dir | A - Grant | $0.00 | +8,490 | 189.0K | +5% | $0 | |
| 2024-06-28 | 2024-06-26 | PHR | Goldstein Lainie | Dir | A - Grant | $0.00 | +8,490 | 40.2K | +27% | $0 | |
| 2024-06-28 | 2024-06-26 | PHR | Egbuonu-Davis Lisa | Dir | A - Grant | $0.00 | +8,490 | 19.5K | +77% | $0 | |
| I | 2024-06-24 | 2024-06-21 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $20.24 | -27 | 6,953 | -0.4% | -$546.48 |
| 2024-06-24 | 2024-06-21 | PHR | Gunzburg Janet | Principal Accounting Off | S - Sale | $20.24 | -114 | 34.8K | -0.3% | -$2,307 | |
| MI | 2024-06-21 | 2024-06-18+ | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $19.53 | -107 | 7,046 | -1% | -$2,089 |
| 2024-05-02 | 2024-04-30 | PHR | CAHILL EDWARD L | Dir | A - Grant | $20.74 | +482 | 46.1K | +1% | +$9,997 | |
| 2024-05-02 | 2024-04-30 | PHR | Goldstein Lainie | Dir | A - Grant | $20.74 | +482 | 31.7K | +2% | +$9,997 | |
| 2024-05-02 | 2024-04-30 | PHR | Munson Gillian | Dir | A - Grant | $20.74 | +482 | 27.3K | +2% | +$9,997 | |
| 2024-05-02 | 2024-05-01 | PHR | Gunzburg Janet | Principal Accounting Off | S - Sale | $21.00 | -286 | 34.9K | -0.8% | -$6,006 | |
| 2024-04-19 | 2024-04-18 | PHR | Gunzburg Janet | Principal Accounting Off | S - Sale | $22.85 | -912 | 35.2K | -3% | -$20.8K | |
| I | 2024-04-19 | 2024-04-18 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $22.85 | -269 | 7,087 | -4% | -$6,147 |
| 2024-04-17 | 2024-04-15 | PHR | VanDuyn Amy Beth | SVP, Human Resources | S - Sale | $22.86 | -685 | 119.0K | -0.6% | -$15.7K | |
| 2024-04-17 | 2024-04-15 | PHR | Hoffman Allison C | GC, Sec | S - Sale | $22.86 | -1,238 | 135.6K | -0.9% | -$28.3K | |
| 2024-04-17 | 2024-04-15 | PHR | Roberts Evan | COO | S - Sale | $22.86 | -2,029 | 754.9K | -0.3% | -$46.4K | |
| 2024-04-17 | 2024-04-15 | PHR | Gandhi Balaji | CFO | S - Sale | $22.86 | -948 | 97.2K | -1.0% | -$21.7K | |
| 2024-04-17 | 2024-04-15 | PHR | Indig Chaim | CEO, Dir | S - Sale | $22.86 | -3,392 | 1.22M | -0.3% | -$77.5K | |
| 2024-04-17 | 2024-04-15 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $22.86 | -2,212 | 204.0K | -1% | -$50.6K | |
| T | 2024-04-12 | 2024-04-10 | PHR | Gunzburg Janet | Principal Accounting Off | S - Sale | $23.10 | -2,768 | 36.1K | -7% | -$63.9K |
| M | 2024-04-10 | 2024-04-08 | PHR | Indig Chaim | CEO, Dir | S - Sale | $22.62 | -12.0K | 1.23M | -1.0% | -$272.5K |
| M | 2024-04-10 | 2024-03-19+ | PHR | Gunzburg Janet | Principal Accounting Off | S - Sale | $23.03 | -4,526 | 40.6K | -10% | -$104.2K |
| MT | 2024-04-10 | 2024-04-08+ | PHR | Hoffman Allison C | GC, Sec | S - Sale | $22.99 | -10.2K | 136.9K | -7% | -$233.9K |
| M | 2024-04-10 | 2024-04-08 | PHR | Gandhi Balaji | CFO | S - Sale | $22.62 | -7,778 | 98.3K | -7% | -$176.0K |
| MI | 2024-04-10 | 2024-04-08 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $22.62 | -247 | 7,358 | -3% | -$5,588 |
| M | 2024-04-10 | 2024-04-08 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $22.62 | -3,914 | 206.3K | -2% | -$88.6K |
| DM | 2024-04-10 | 2024-04-08 | PHR | Roberts Evan | COO | S - Sale+OE | $22.62 | -7,178 | 733.6K | -1.0% | -$162.4K |
| D | 2024-04-10 | 2024-04-09 | PHR | Roberts Evan | COO | M - OptEx | $2.03 | +23.3K | 756.9K | +3% | +$47.4K |
| MT | 2024-04-10 | 2024-04-08+ | PHR | VanDuyn Amy Beth | SVP, Human Resources | S - Sale | $23.05 | -7,122 | 123.5K | -5% | -$164.2K |
| 2024-04-09 | 2024-04-05 | PHR | VanDuyn Amy Beth | SVP, Human Resources | A - Grant | — | +7,122 | 126.8K | +6% | — | |
| I | 2024-04-09 | 2024-04-05 | PHR | Linetsky David | SVP, Life Sciences | A - Grant | — | +508 | 7,603 | +7% | — |
| 2024-04-09 | 2024-04-05 | PHR | Linetsky David | SVP, Life Sciences | A - Grant | — | +6,105 | 210.2K | +3% | — | |
| 2024-04-09 | 2024-04-05 | PHR | Hoffman Allison C | GC, Sec | A - Grant | — | +10.2K | 147.0K | +7% | — | |
| 2024-04-09 | 2024-04-05 | PHR | Gunzburg Janet | Principal Accounting Off | A - Grant | — | +4,477 | 43.4K | +11% | — | |
| 2024-04-09 | 2024-04-05 | PHR | Roberts Evan | COO | A - Grant | — | +12.2K | 740.8K | +2% | — | |
| 2024-04-09 | 2024-04-05 | PHR | Indig Chaim | CEO, Dir | A - Grant | — | +21.0K | 1.24M | +2% | — | |
| 2024-04-09 | 2024-04-05 | PHR | Gandhi Balaji | CFO | A - Grant | — | +11.9K | 106.0K | +13% | — | |
| 2024-03-27 | 2024-03-25 | PHR | Gandhi Balaji | CFO | S - Sale | $23.21 | -3,504 | 94.0K | -4% | -$81.3K | |
| MT | 2024-03-25 | 2024-03-21 | PHR | Roberts Evan | COO | S - Sale | $23.52 | -26.0K | 728.6K | -3% | -$610.6K |
| I | 2024-03-21 | 2024-03-20 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $23.66 | -30 | 7,095 | -0.4% | -$709.80 |
| 2024-03-21 | 2024-03-20 | PHR | Gunzburg Janet | Principal Accounting Off | S - Sale | $23.66 | -137 | 38.9K | -0.4% | -$3,241 | |
| MI | 2024-03-20 | 2024-03-18+ | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $23.16 | -448 | 7,125 | -6% | -$10.4K |
| T | 2024-02-13 | 2024-02-09 | PHR | Gunzburg Janet | Principal Accounting Off | S - Sale | $28.00 | -480 | 39.1K | -1% | -$13.4K |
| T | 2024-02-06 | 2024-02-02 | PHR | Gunzburg Janet | Principal Accounting Off | S - Sale | $27.00 | -480 | 39.6K | -1% | -$13.0K |
| MT | 2024-02-02 | 2024-01-12+ | PHR | Gunzburg Janet | Principal Accounting Off | S - Sale | $25.27 | -533 | 40.0K | -1% | -$13.5K |
| 2024-02-01 | 2024-01-31 | PHR | Munson Gillian | Dir | A - Grant | $25.48 | +392 | 26.8K | +1% | +$9,988 | |
| 2024-02-01 | 2024-01-31 | PHR | CAHILL EDWARD L | Dir | A - Grant | $25.48 | +392 | 45.6K | +0.9% | +$9,988 | |
| 2024-02-01 | 2024-01-31 | PHR | Goldstein Lainie | Dir | A - Grant | $25.48 | +392 | 31.2K | +1% | +$9,988 | |
| M | 2024-01-18 | 2024-01-16+ | PHR | Gandhi Balaji | CFO | S - Sale | $24.16 | -10.1K | 106.7K | -9% | -$244.6K |
| M | 2024-01-18 | 2024-01-16+ | PHR | VanDuyn Amy Beth | SVP, Human Resources | S - Sale | $24.15 | -11.0K | 129.9K | -8% | -$264.5K |
| M | 2024-01-18 | 2024-01-16+ | PHR | Roberts Evan | COO | S - Sale | $24.14 | -43.3K | 795.6K | -5% | -$1.05M |
| M | 2024-01-18 | 2024-01-16+ | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $24.15 | -33.0K | 204.1K | -14% | -$796.4K |
| M | 2024-01-18 | 2024-01-16+ | PHR | Indig Chaim | CEO, Dir | S - Sale | $24.14 | -67.5K | 1.22M | -5% | -$1.63M |
| M | 2024-01-18 | 2024-01-16+ | PHR | Hoffman Allison C | GC, Sec | S - Sale | $24.18 | -8,921 | 144.5K | -6% | -$215.7K |
| M | 2024-01-18 | 2024-01-16+ | PHR | Davidoff Michael J. | SVP, Payer Business | S - Sale | $24.15 | -19.0K | 91.1K | -17% | -$458.5K |
| 2024-01-04 | 2024-01-02 | PHR | Linetsky David | SVP, Life Sciences | A - Grant | $0.00 | +22.0K | 237.0K | +10% | $0 | |
| 2024-01-04 | 2024-01-02 | PHR | Gandhi Balaji | CFO | A - Grant | $0.00 | +22.0K | 107.7K | +26% | $0 | |
| 2024-01-04 | 2024-01-02 | PHR | Indig Chaim | CEO, Dir | A - Grant | $0.00 | +42.0K | 1.28M | +3% | $0 | |
| 2024-01-04 | 2024-01-02 | PHR | VanDuyn Amy Beth | SVP, Human Resources | A - Grant | $0.00 | +12.5K | 130.6K | +11% | $0 | |
| 2024-01-04 | 2024-01-02 | PHR | Roberts Evan | COO | A - Grant | $0.00 | +22.0K | 797.9K | +3% | $0 | |
| 2024-01-04 | 2024-01-02 | PHR | Hoffman Allison C | GC, Sec | A - Grant | $0.00 | +30.5K | 145.8K | +26% | $0 | |
| 2024-01-02 | 2023-12-31 | PHR | Hoffman Allison C | GC, Sec | A - Grant | $19.68 | +255 | 115.3K | +0.2% | +$5,018 | |
| MI | 2023-12-20 | 2023-12-18+ | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $23.21 | -259 | 7,598 | -3% | -$6,010 |
| 2023-12-20 | 2023-12-19 | PHR | Gunzburg Janet | Principal Accounting Off | S - Sale | $23.72 | -118 | 40.6K | -0.3% | -$2,799 | |
| 2023-11-02 | 2023-10-31 | PHR | Goldstein Lainie | Dir | A - Grant | $13.66 | +732 | 30.8K | +2% | +$9,999 | |
| 2023-11-02 | 2023-10-31 | PHR | Munson Gillian | Dir | A - Grant | $13.66 | +732 | 26.4K | +3% | +$9,999 | |
| 2023-11-02 | 2023-11-01 | PHR | Gunzburg Janet | Principal Accounting Off | S - Sale | $13.38 | -298 | 40.7K | -0.7% | -$3,987 | |
| D | 2023-11-02 | 2023-10-31 | PHR | Roberts Evan | COO | M - OptEx | $2.03 | +30.0K | 775.9K | +4% | +$60.9K |
| 2023-11-02 | 2023-10-31 | PHR | CAHILL EDWARD L | Dir | A - Grant | $13.66 | +732 | 45.2K | +2% | +$9,999 | |
| 2023-10-17 | 2023-10-16 | PHR | Davidoff Michael J. | SVP, Payer Business | S - Sale | $16.61 | -1,198 | 92.4K | -1% | -$19.9K | |
| 2023-10-17 | 2023-10-16 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $16.61 | -2,078 | 215.0K | -1.0% | -$34.5K | |
| 2023-10-17 | 2023-10-16 | PHR | Indig Chaim | CEO, Dir | S - Sale | $16.61 | -3,295 | 1.24M | -0.3% | -$54.7K | |
| 2023-10-17 | 2023-10-16 | PHR | Hoffman Allison C | GC, Sec | S - Sale | $16.61 | -1,297 | 115.0K | -1% | -$21.5K | |
| 2023-10-17 | 2023-10-16 | PHR | VanDuyn Amy Beth | SVP, Human Resources | S - Sale | $16.61 | -665 | 118.1K | -0.6% | -$11.0K | |
| 2023-10-17 | 2023-10-16 | PHR | Roberts Evan | COO | S - Sale | $16.61 | -1,971 | 745.9K | -0.3% | -$32.7K | |
| 2023-10-17 | 2023-10-16 | PHR | Gandhi Balaji | CFO | S - Sale | $16.61 | -861 | 85.7K | -1.0% | -$14.3K | |
| 2023-09-20 | 2023-09-18 | PHR | Gunzburg Janet | Principal Accounting Off | S - Sale | $19.79 | -125 | 41.0K | -0.3% | -$2,474 | |
| MI | 2023-09-20 | 2023-09-18 | PHR | Linetsky David | SVP, Life Sciences | S - Sale | $19.67 | -130 | 7,896 | -2% | -$2,556 |
| MT | 2023-09-14 | 2023-09-13+ | PHR | Davidoff Michael J. | SVP, Payer Business | S - Sale | $20.26 | -6,559 | 96.5K | -6% | -$132.9K |
| T | 2023-09-14 | 2023-09-12 | PHR | Davidoff Michael J. | SVP, Payer Business | A - Grant | — | +6,559 | 100.1K | +7% | — |
Purchase Sale Sale after option exercise All abbreviations